BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 29931050)

  • 1. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo cardiac role of migfilin during experimental pressure overload.
    Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
    Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
    Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
    Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure.
    Remes A; Wagner AH; Schmiedel N; Heckmann M; Ruf T; Ding L; Jungmann A; Senger F; Katus HA; Ullrich ND; Frey N; Hecker M; Müller OJ
    Basic Res Cardiol; 2021 Jun; 116(1):38. PubMed ID: 34089101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
    Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
    Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
    Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
    J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.